Thomas Hartle has joined a legal effort to make psychedelic therapy more accessible to Canadians. (CTV News)
Thomas Hartle, a 56-year-old man from Saskatoon, made history as the first person in Canada to legally access psilocybin-assisted therapy, commonly known as magic mushroom therapy. His journey began in 2020 when he sought relief from severe end-of-life anxiety caused by a terminal cancer diagnosis. Thomas's quest for peace led him to psilocybin, a psychedelic substance that has gained attention for its potential therapeutic benefits.
His wife, Marliss Hartle, recalls the transformative impact the therapy had on Thomas. "I really felt like it made him be here for years longer because he was so passionate about it," she said. Marliss observed a significant change in Thomas after his first psilocybin treatment. "He stopped worrying so much, right? That anxiety was lifted," she shared, highlighting how the therapy provided him with a sense of calm and acceptance in the face of his mortality.
Thomas himself had previously spoken about how the therapy allowed him to confront his fears and emotions more openly, as opposed to merely suppressing them with conventional antidepressants. Unfortunately, his Health Canada exemption, which allowed him to access the therapy legally, expired after a year. Despite reapplying, his application was denied in 2023, forcing Thomas and Marliss to seek treatment outside of Canada, which proved challenging and expensive.
Thomas passed away on August 13, after a decade-long battle with cancer. His legacy, however, continues to inspire others. A close friend, Michael Kydd, has established the Thomas Hartle Memorial Fund through a GoFundMe campaign to honour his life and contribution to the advancement of psilocybin-assisted therapy. "He was such a dear friend, not just to me personally, but I think to so many Canadians and so many people across the world, because he shared his experience so openly and so courageously," Kydd said, emphasizing the profound impact Thomas had on the therapeutic community.
Marliss hopes that her husband’s story will lead to broader access to psilocybin treatment for those in need. "I hope that the psilocybin treatment becomes available for everybody," she stated, reflecting on Thomas's wish to see others benefit from the therapy that gave him solace in his final years.
